RR

Rajat Raj Karanwal

Active Director Director DIN 08647324
DIN 08647324 First appointment Dec 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Rajat Raj Karanwal

Data last updated:

Rajat Raj Karanwal is a Director at R K Medicines Private Ltd (since 2019). The company operates in Healthcare. R K Medicines Private Ltd reported revenue of ₹167 Cr (FY 2025).

DIN 08647324
Primary Designation Director
Industry Healthcare
First Appointment 20 Dec 2019
Oldest Company Age 39 yrs
Largest company R K Medicines Private Ltd · ₹167 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
R K Medicines Private Ltd U74899DL1987PTC028244
Director20 Dec 20191987₹167 Cr (FY 2025)Active

Board colleagues of Rajat Raj Karanwal

NameDINCompanyDesignation
Sushasnt Kumar Sahu08719047R K Medicines Private LtdDirector

Directorship timeline

Open interactive timeline →
R K Medicines Private Ltd
Premium access

Shareholding and investment profile for Rajat Raj Karanwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajat Raj Karanwal

Rajat Raj Karanwal currently holds 1 directorship: R K Medicines Private Ltd (Director, since 20 Dec 2019, revenue ₹167 Cr (FY 2025)).

Rajat Raj Karanwal was first appointed on 20 Dec 2019 as Director at R K Medicines Private Ltd.

The current boards of Rajat Raj Karanwal's companies include Sushasnt Kumar Sahu (R K Medicines Private Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available